Sting agonists for treating bladder cancer and solid tumors
AssigneeVenenum Biodesign, LLC
InventorsBrian F. McGUINNESS, Grant GALLAGHER, Michael S. McQUENEY, Rukiye NAZAN ERASLAN, Gary SCHIEVEN, Jason TRAMA, Axel METZGER, David J. DILLER, David E. KAELIN
Life of this patent
Estimating the term…
Abstract
Methods for treating bladder cancer and solid tumors are disclosed. The methods include administering to a patient a compound of formula 1 Pharmaceutical compositions of compound 1 are also disclosed.
Claims11
- 12. (canceled)
A method for treating bladder cancer comprising administering to a patient in need of treatment for bladder cancer a therapeutically effective amount of a compound of formula 1
- or pharmaceutically acceptable salt thereof, wherein administering said compound of formula 1 is accompanied by radiation therapy.
A method for treating bladder cancer comprising administering to a patient in need of treatment for bladder cancer a therapeutically effective amount of a compound of formula 1
- or pharmaceutically acceptable salt thereof, wherein administering said compound of formula 1 is accompanied by administration of an anti-PD-1 or anti-PD-L1 agent.
A method for treating bladder cancer comprising administering to a patient in need of treatment for bladder cancer a therapeutically effective amount of a compound of formula 1
- or pharmaceutically acceptable salt thereof, wherein said treating is for the purpose of slowing the progression of the disease.
-24. (canceled)
A method for treating solid tumors comprising administering to a patient in need of treatment for a solid tumor a therapeutically effective amount of a compound of formula 1
- or pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.